The Judges Role in Determining Suit Progression In a class action lawsuit involving diabetes drugs, like Ozempic that affect blood sugar levels, its up to the judge to decide whether or not this type of legal proceeding is appropriate
Tu, J., Chen, R., Yang, Y., Cao, W., & Xie, W
Journal of Biological Chemistry, 2014
Trumps executive order directs Kennedy to propose and seek guidance on improving the transparency of the program, prioritizing the selection of high-cost medications and minimizing harmful impacts to drug innovation
[1] Commonly prescribed GLP-1 agonists include semaglutide (Ozempic for diabetes, Wegovy for weight management), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon)
Semaglutide is instead eliminated predominantly through proteolytic degradation distributed across multiple tissues (no single organ dominates clearance), with minor renal excretion of metabolite fragments